Literature DB >> 29386863

Pharmaceutical Approval Update.

Michele B Kaufman.   

Abstract

Benznidazole for pediatric patients with Chagas disease; vestronidase alfa-vjbk (Mepsevii) for adults and children with mucopolysaccharidosis type VII; and hepatitis B vaccine (recombinant), adjuvanted (Heplisav-B), for the prevention of infection caused by all known subtypes of hepatitis B virus in adults.

Entities:  

Year:  2018        PMID： 29386863      PMCID： PMC5768295     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  2 in total

1.  A new case report of severe mucopolysaccharidosis type VII: diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy.

Authors:  Francesca Furlan; Attilio Rovelli; Miriam Rigoldi; Mirella Filocamo; Barbara Tappino; Douglas Friday; Serena Gasperini; Silvana Mariani; Claudia Izzi; Maria Pia Bondioni; Cinzia Gellera; Anna Venerando; Nicoletta Villa; Maria Del Carmen Rodriguez Perez; Fabio Pavan; Andrea Biondi; Rossella Parini
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

Review 2.  Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development Therapeutics.

Authors:  Juergen Scharner; Isabel Aznarez
Journal:  Mol Ther       Date:  2020-12-25       Impact factor: 11.454
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.